Posts Tagged ‘patent expiration’

Drug Patent Expirations for the Week of February 4, 2024

NATESTO (testosterone) Acerus Patent: 8,784,869 Expiration: Feb 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pate…


New patent expiration for Acerus drug NATESTO

Annual Drug Patent Expirations for NATESTO Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Acerus drug NATESTO appeared first on D…


Biotechblog